A study showed that cancer funding is disproportionately skewed, leaving many cancers with high mortality rates and those affecting Black patients underfunded. NCI and cancer-related nonprofit organizations donated $13.66 billion to cancer research between 2015 and 2018. Despite this, funding for breast cancer exceeded that of lung, colorectal, and pancreatic cancers combined. In addition, white patients benefitted from funding more than Black patients. The disparity in funding also affects the number of clinical trials for specific cancers. The study’s lead researcher suggests that diversifying funding across different types of cancer would help attract talent and lead to advancements in treatment.
Source link
Lack of resource ‘equality’ means research of the deadliest cancers is often underfunded
